 |
|
Pathogenesis of Inflammatory Bowel Diseases
Masakazu Nagahori, Yasuhiro Nemoto, Mamoru Watanabe
Intest Res. 2010;8(1):9-17. Published online 2010 Jun 30 DOI: https://doi.org/10.5217/ir.2010.8.1.9
|
|
Citations to this article as recorded by
 Metformin alleviates inflammation in oxazolone induced ulcerative colitis in rats: plausible role of sphingosine kinase 1/sphingosine 1 phosphate signaling pathway
Nageh Ahmed El-Mahdy, Magda El-Sayed El-Sayad, Aya Hassan El-Kadem, Sally EL-Sayed Abu-Risha
Immunopharmacology and Immunotoxicology.2021; 43(2): 192. CrossRef The efficacy of conditioned medium released by tonsil-derived mesenchymal stem cells in a chronic murine colitis model
Ko Eun Lee, Sung-Ae Jung, Yang-Hee Joo, Eun Mi Song, Chang Mo Moon, Seong-Eun Kim, Inho Jo, Debabrata Banerjee
PLOS ONE.2019; 14(12): e0225739. CrossRef Interleukin‐23p19 expression in patients with ulcerative colitis and its relation to disease severity
Hanan El‐Bassat, Lobna AboAli, Sahar El Yamany, Hanan Al Shenawy, Rasha A. Al Din, Atef Taha
Advances in Digestive Medicine.2016; 3(3): 88. CrossRef Does Carotid Intima-Media Thickness Increase in Patients With Inflammatory Bowel Disease?
Kyeong Ok Kim, Byung Ik Jang, Si Hyung Lee
Intestinal Research.2014; 12(4): 293. CrossRef The Association between the Therapeutic Agent and the Compliance of the Patients with Inflammatory Bowel Diseases
Yun-Seong Kang, So Young Kim, Min Ho Jo, Hyoun Woo Kang, Jun Kyu Lee, Yun Jeong Lim, Moon Soo Koh, Jin Ho Lee, Chang Hun Yang, Jae Hak Kim
The Korean Journal of Gastroenterology.2013; 61(6): 313. CrossRef Targeting sphingosine kinase 1 (SphK1) and apoptosis by colon-specific delivery formula of resveratrol in treatment of experimental ulcerative colitis in rats
Amany A. Abdin
European Journal of Pharmacology.2013; 718(1-3): 145. CrossRef Novel Pharmacological Approaches for Inflammatory Bowel Disease: Targeting Key Intracellular Pathways and the IL-23/IL-17 Axis
Leo R. Fitzpatrick
International Journal of Inflammation.2012; 2012: 1. CrossRef
|